The Research Question What is the evidence on diagnostic test performance and clinical outcomes of supplemental screening of women with dense breasts with.

Slides:



Advertisements
Similar presentations
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Advertisements

BREAST CANCER SCREENING Anoop Agrawal, M.D.. NEW USPSTF BREAST SCREENING GUIDELINES Published by US Preventative Screening Task Force in November 2009.
Breast Cancer Screening What’s New to Know? The Issue of Breast Density Catherine Babcook MD Partner, Mountain Medical Physician Specialists Medical Director.
Screening Mammography: Regret or no regret? Joint Hospital Surgical Grand Round 19 May 2007 Yvonne Tsang Prince of Wales Hospital.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
WHY DIGIT L MAMMOGRAPHY comes to Advocate Lutheran General Hospital 3D Mammography.
Breast Density A patient guide.
TriLHIN ICS Orientation Workshop July 16, 2014 Dr. Jan Owen, MD, CCFP, FCFP Regional Primary Care Lead, SWRCP Screening Cancer.
Geriatric Health Maintenance: Cancer Screening Linda DeCherrie, MD Geriatric Fellow Mount Sinai Hospital.
299. Breast Cancer Screening Paul Jones, PGY2 Resident Rounds 25 July 2012.
© Open University Press, 2004 Overview Prevention and screening Psychological predictors of screening The ethics and usefulness of screening? Psychological.
Breast cancer screening Mammography is the most widely used screening modality, with solid evidence of benefit for women aged 40 to 74 years Clinical breast.
MAMOGRAPHY. Mammography is the process of using low- energy X-rays (usually around 30 kVp) to examine the human breast, which is used as a diagnostic.
ACRIN Protocol 6666 ACRIN Protocol 6666 Screening Breast Ultrasound in High-Risk Women Made possible by grants from the Avon Foundation and National Cancer.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Prevention and Early Detection of Breast Cancer: Weighing the Risks and Benefits Kathy J. Helzlsouer, M.D., M.H.S. Prevention and Research Center, Women’s.
5 Most Common Cancers. 1 in 2 men and 1 in 3 women in Australia will be diagnosed with cancer before the age of 85.
ACRIN Breast Committee Fall Meeting : Comparison of Full-Field Digital Mammography with Digital Breast Tomosynthesis Image Acquisition in Relation.
 Self-Examination  Clinical Examination  Mammography  Biopsy  Does prevailing ‘Standard of Care’ save lives? ©2012 Philip Hoekstra, PhD.
Improvement in Screening Radiologists’ Performance in an Organized Screening Program Nancy A. T. Wadden, MD, FRCPC Gregory Doyle, BSc, MBA Breast Screening.
Understanding Factors That Affect Mammography Performance: Contribution of the BCSC Bonnie C. Yankaskas, PhD Professor of Radiology University of North.
FAVOR F actors A ssociated with V ariability O f R adiologists (2000 to present) Supported by grants from the National Cancer Institute (R01 CA ;
Measuring and Improving Radiologists’ Interpretative Performance on Screening Mammography Karla Kerlikowske, MD Diana Buist, PhD Patricia Carney, PhD Berta.
In The Name of God BREAST IMAGING N. Ahmadinejad Medical Imaging Center TUMS.
40% of women have dense breasts. RESULT: Current 2D mammography makes it difficult to detect cancers in dense breast tissue because both appear white.
Breast Cancer Surveillance Consortium: Progress in Understanding Screening Delivery and Early Detection Rachel Ballard-Barbash, MD, MPH, Associate Director,
Evidence base of clinical diagnosis 邓贝贝 张棣 王迎. Category of diagnostic test laboratory examination medical history and information from physical examination.
Using Simulation and Decision Modeling to Inform Decision Making AHRQ Annual Meeting Sept. 8, 2008.
ACRIN Breast Committee Fall Meeting CADe study Etta Pisano, MD Martin Yaffe PhD Elodia Cole, MS Zheng Zhang, PhD ACRIN Breast Committee.
Breast Density: Black, White and Shades of Gray Jen Rusiecki, MD VA Pittsburgh Health System Women’s Health Fellow AMWA Hot Topic 2016.
“Beyond Mammography” Len Saputo, MD For a free download of this go to this URL:
Tomosynthesis vs Digital Mammography What do the published studies show? Why do we need TMIST? Etta D. Pisano, MD Harvard Medical School Beth Israel Deaconess.
Improving Cancer Screening Among Low Income Women: a randomized controlled trial NCI R01 CA87776 Allen J. Dietrich, MD NAPCRG 2005 Annual Meeting October.
Iraj Khalkhali M.D., F.A.C.R., F.A.C.N.M.
Dr. Julia Flukinger Breast Radiologist, Director Breast MRI, Advanced Radiology May 21, 2106.
Evaluation of the Community Patient Navigation Program within the Community Education and Outreach Initiative (CEOI) Patient Navigation is one strategy.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Finding Answers: Disparities Research for Change A National Program of the Robert Wood Johnson Foundation at the University of Chicago Interventions to.
From: Screening for Syphilis Infection in Pregnancy: U. S
Breast Screening and Assessment
TMIST A Breast Cancer Screening Trial
Mammograms and Breast Exams: When to start /stop mammograms
IEE: New Zealand Trevor Everett.
Nut and Bolts of Critical Appraisal of Medical Literature
Is ultrasound valuable in breast cancer screening
From: Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
From: Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern.
From: Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement Ann Intern Med. 2013;159(10):
Definition of Cancer Screening
Breast Screening and Risk Assessment
Roni Talukdar, MD.
Breast Imaging Ravi Adhikary, MD.
سرطان الثدي Breast Cancer
The efficacy of using CAD for detection of
Periodic Health evaluation
Presenter: Wen-Ching Lan
Abbreviated Protocols for Breast Cancer Screening
Breast Density and Breast Cancer Risk: A Practical Review
Seth D. Crockett, A. Sidney Barritt, Nicholas J. Shaheen 
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Information Retrieval for Evidence-based Practice
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
The Potential Effect of Digital Breast Tomosynthesis on the Benign Biopsy Rate in Women Recalled within the UK Breast Screening Programme When compared.
Local Tumor Staging of Breast Cancer: Digital Mammography versus Digital Mammography Plus Tomosynthesis Sensitivity was higher for combined digital mammography.
Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States Screening mammography performance metrics are.
Diagnosis of breast cancer in women age 40 and younger: Delays in diagnosis result from underuse of genetic testing and breast imaging 95% of patients.
imaging modalities for Breast screening
Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer A.
Tumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis: The Malmö Breast Tomosynthesis Screening Trial.
Presentation transcript:

The Research Question What is the evidence on diagnostic test performance and clinical outcomes of supplemental screening of women with dense breasts with ultrasound (US), MRI, or digital breast tomosynthesis (DBT)? CR37 Adjunctive Screening for Breast Cancer in Women with Dense Breasts: A Systematic Review Joy Melnikow, MD, MPH; Joshua Fenton, MD, MPH; Evelyn Whitlock, MD, MPH; Diana Miglioretti, PhD; Jamie Thompson, MPH; Meghan Weyrich, MPH

What the Researchers Did A systematic review of the published, English-language medical literature on: Sensitivity, specificity, PPV, cancer detection rates recall rates, and long term outcomes of supplemental screening (after a normal mammogram) with US, MRI or DBT for women with dense breasts (BI-RADS c/d density)

What the Researchers Found No studies of breast cancer morbidity or mortality Hand-held US Sensitivity 80-83%; specificity 86-94%; PPV 3-8%. Additional cancer detection 4.4 per 1,000 exams; recall rates 14% (one study) MRI Sensitivity 75-100%; specificity 78-89%; PPV 3-33%. Additional cancer detection 4 to 29 per 1,000 exams; recall rates 12%-24% per 1,000 exams. DBT Additional cancer detection: Increased by about 1 cancer per 1000 exams (4/1000 to 5/1000) Recall rates: 7-11% with DBT + mammography vs 9-17% with mammography alone 2 good quality studies of supplemental handheld breast ultrasound screening and 3 good quality studies of breast MRI provided data on sensitivity, specificity, positive predictive value, recall rates, and cancer detection rates. No studies of DBT addressed test performance characteristics in women with dense breasts. 3 fair quality studies of DBT examined cancer detection rates and recall rates

What This Means for Clinical Practice No evidence on whether supplemental screening reduces breast cancer mortality or morbidity Rigorous studies with long term follow-up are needed Supplemental US and MRI increased cancer detection but had high false positive rates DBT may reduce recall rates but evidence for women with dense breasts is very preliminary Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Feb 16;164(4):268-78. doi: 10.7326/M15-1789. Epub 2016 Jan 12. PubMed PMID: 26757021.